|
|
Volumn 91, Issue 4, 2003, Pages 421-422
|
|
Gene therapy, urological disease and the pharmaceutical industry
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE DEAMINASE;
CASPASE 7;
NITRIC OXIDE SYNTHASE;
APOPTOSIS;
BIOTECHNOLOGY;
BLADDER CANCER;
CYSTIC FIBROSIS;
DNA PROTEIN COMPLEX;
DNA VECTOR;
DRUG INDUSTRY;
ENCAPSULATION;
ENZYME DEFICIENCY;
ERECTILE DYSFUNCTION;
GENE CONTROL;
GENE DELIVERY SYSTEM;
GENE EXPRESSION;
GENE OVEREXPRESSION;
GENE THERAPY;
GENOME;
GERM CELL;
GERM LINE;
HEMOPHILIA;
PATHOGENICITY;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
RISK BENEFIT ANALYSIS;
SOMATIC CELL GENETICS;
STRESS INCONTINENCE;
TISSUE ENGINEERING;
URINARY TRACT DISEASE;
DRUG INDUSTRY;
GENE THERAPY;
HUMANS;
UROLOGIC DISEASES;
|
|
EID: 0037351523
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1464-410X.2003.04102.x Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
